+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Fungal Pneumonia - Pipeline Insight, 2025 - Product Thumbnail Image

Fungal Pneumonia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gene Therapies For Cardiomyopathies - Pipeline Insight, 2025 - Product Thumbnail Image

Gene Therapies For Cardiomyopathies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hematuria - Pipeline Insight, 2025 - Product Thumbnail Image

Hematuria - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Leber's Hereditary Optic Neuropathy - Pipeline Insight, 2025 - Product Thumbnail Image

Leber's Hereditary Optic Neuropathy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Lumbar Spondylolisthesis - Pipeline Insight, 2025 - Product Thumbnail Image

Lumbar Spondylolisthesis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Mallory-weiss Tear - Pipeline Insight, 2025 - Product Thumbnail Image

Mallory-weiss Tear - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Mild Cognitive Impairment - Pipeline Insight, 2025 - Product Thumbnail Image

Mild Cognitive Impairment - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Myofascial Pain Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Myofascial Pain Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Neurotrophic Keratopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Neurotrophic Keratopathy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Onycholysis - Pipeline Insight, 2025 - Product Thumbnail Image

Onycholysis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Retinal Edema - Pipeline Insight, 2025 - Product Thumbnail Image

Retinal Edema - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Ventricular Hypertrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Ventricular Hypertrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Neurotrophic Keratitis - Pipeline Insight, 2025 - Product Thumbnail Image

Neurotrophic Keratitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Non-Opioid Strontium Chloride - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Opioid Strontium Chloride - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Ocular Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Ocular Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 65 Pages
  • Global
From
Oncolytic Adenovirus - Pipeline Insight, 2025 - Product Thumbnail Image

Oncolytic Adenovirus - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Oral Dysplasia - Pipeline Insight, 2025 - Product Thumbnail Image

Oral Dysplasia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Overactive Bowel Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Overactive Bowel Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more